Drug Trial Radar · NCT00427388
Steroids In caRdiac Surgery Trial (SIRS Trial)
Last checked: Nov 19, 2026Latest source record: Aug 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
7,507
Actual
Start
Jun 2007
Primary completion
Feb 2014
Study completion Aug 2014
Sponsor
- Lead sponsor
- Population Health Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- First posted
- Jan 29, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SIRS trial is a large simple study in which high-risk patients undergoing cardiac surgery requiring the use of cardiopulmonary bypass (CPB) are randomly allocated to receive a pulse dose of Methylprednisolone or a matching placebo. Cardiopulmonary bypass initiates a systemic inflammatory response that facilitates development of post-operative complications. SIRS will confirm or deny the potential clinical benefits of suppressing this response through the use of systemic steroids. Specifically, does 250 mg of intravenous Methylprednisolone given twice, once on anesthetic induction and again on CPB initiation, result in improved early survival and less myocardial infarction in high-risk cardiac surgery patients requiring CPB?
Conditions
- Cardiac Surgical Procedures
- Cardiopulmonary Bypass
- Systemic Inflammatory Response Syndrome
Interventions
MethylprednisoloneDrug
Given by IV in 2 doses (250 mg each dose for a total of 500 mg)
PlaceboOther
Given in 2 IV doses (approximately 4 ml of 0.9% normal saline solution in each dose)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality at 30 daysTime frame: 30 days post-randomization
- CompositeTime frame: 30 days post-randomization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hamilton General Hospital
Hamilton, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.